EU PHARMACEUTICAL LEGISLATION
In order to ensure regular access to plasma medicines for those in need, it is critical that policymakers acknowledge the clinical urgency for increased plasma collection in Europe. Discover the latest updates on legislation surrounding the broader European plasma donation ecosystem.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
EU Pharmaceutical legislation[Directive 2001/83/EC1)
Consolidated text: Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use
All
This is some text inside of a div block.
This is some text inside of a div block.
EU Pharmaceutical legislation[Directive 2001/83/EC1)
Consolidated text: Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use
All
EU pharmaceutical legislation
This is some text inside of a div block.
EU Pharma strategy
Adopted on 25 November 2020, the Pharmaceutical Strategy for EuropeEN••• (reader-friendly versionEN•••) aims at creating a future proof regulatory framework and at supporting the industry in promoting research and technologies that reach patients to fulfil their therapeutic needs while addressing market failures. It will also consider the weaknesses exposed by the coronavirus pandemic and take appropriate actions to strengthen the system.
All
This is some text inside of a div block.
This is some text inside of a div block.
EU Pharma strategy
Adopted on 25 November 2020, the Pharmaceutical Strategy for EuropeEN••• (reader-friendly versionEN•••) aims at creating a future proof regulatory framework and at supporting the industry in promoting research and technologies that reach patients to fulfil their therapeutic needs while addressing market failures. It will also consider the weaknesses exposed by the coronavirus pandemic and take appropriate actions to strengthen the system.
All
EU pharmaceutical legislation
This is some text inside of a div block.
European Commission: Roadmap
The EU is launching a new strategy to improve and accelerate patients’ access to safe and affordable medicines and to support innovation in the EU pharmaceutical industry.
All
This is some text inside of a div block.
This is some text inside of a div block.
European Commission: Roadmap
The EU is launching a new strategy to improve and accelerate patients’ access to safe and affordable medicines and to support innovation in the EU pharmaceutical industry.
All
EU pharmaceutical legislation
This is some text inside of a div block.
Roadmap: Revision of the EU general pharmaceuticals legislation
As part of the EU pharmaceuticals strategy, and drawing lessons from the COVID-19 pandemic, the Commission plans to evaluate and revise the EU’s general legislation on medicines for human use to ensure a future-proof and crisis-resistant medicines regulatory system.
All
This is some text inside of a div block.
This is some text inside of a div block.
Roadmap: Revision of the EU general pharmaceuticals legislation
As part of the EU pharmaceuticals strategy, and drawing lessons from the COVID-19 pandemic, the Commission plans to evaluate and revise the EU’s general legislation on medicines for human use to ensure a future-proof and crisis-resistant medicines regulatory system.
All
EU pharmaceutical legislation
This is some text inside of a div block.